How much funding has Atomo Diagnostics raised?

Atomo Diagnostics has raised $7.1M in total funding, most recently a Grant round.

Who are Atomo Diagnostics's investors?

Atomo Diagnostics's investors include Bill & Melinda Gates Foundation, Global Health Investment Corporation.

When was Atomo Diagnostics founded?

Atomo Diagnostics was founded in 2010.

Where is Atomo Diagnostics headquartered?

Atomo Diagnostics is headquartered in Sydney, Australia.

What industry is Atomo Diagnostics in?

Atomo Diagnostics operates in Diagnostics, Medical Devices.

How many employees does Atomo Diagnostics have?

Atomo Diagnostics has 11-50 employees.

Atomo Diagnostics

Empowering Decentralised Testing

Sydney, Australia · Founded 2010 · $7.1M raised

Diagnostics

Medical Devices

Headquarters: Sydney
Employees: 11–50
Founded: 2010
Business Model: B2B

Website: atomodiagnostics.com
Total Funding: $7.1M
Last Round: $3.6M GrantOct 2016
Rounds: 2

About

Atomo Diagnostics is an Australian medical device manufacturer and global leader in the user-centred design of innovative, accurate, and reliable rapid diagnostics. Founded in 2010 and headquartered in Leichhardt, Sydney, the company is listed on the Australian Securities Exchange (ASX: AT1). Atomo's proprietary platform technologies improve rapid diagnostic testing by dramatically elevating ease-of-use and proven performance — achieving 90% reduction in blood delivery errors, 100% reduction in buffer delivery errors, and 40% reduction in procedure time compared to traditional lateral flow tests. The company introduced its AtomoRapid platform in 2013, covering both professional-use and self-test applications. Atomo's platforms have achieved WHO Prequalification, FDA 510(k) clearance, and CE marking, with over 7 million platforms sold across 40+ countries.

Summary

Atomo Diagnostics is a Diagnostics company based in Sydney, Australia, founded in 2010. It has raised $7.1M in total across 2 rounds, most recently a $3.6M Grant round in Oct 2016. Investors include Bill & Melinda Gates Foundation and Global Health Investment Corporation.